Lv1
60 积分 2026-01-09 加入
Clinical Efficacy and Safety of Liraglutide and Dapagliflozin on Glucose and Lipid Metabolism and Insulin Function in Patients with Type 2 Diabetes Mellitus
3个月前
已关闭
Weekend warrior physical activity pattern and risk of all-cause and cardiovascular mortality among US adults with metabolic dysfunction-associated steatotic liver disease: A prospective cohort study of NHANES 2007-2018
3个月前
已完结
Association of accelerometer-measured physical activity patterns with cardiovascular diseases and mortality in people with osteoarthritis
3个月前
已完结
[Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)]
4个月前
已关闭
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
4个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
4个月前
已完结
Accelerometer-derived ‘weekend warrior’ physical activity and incident cardiovascular disease among people with diabetes
6个月前
已完结
The associations of weekend warrior and other physical activity patterns with the risk of all-cause and cardiovascular disease mortality in people with diabetes mellitus and chronic kidney disease: from NHANES 2007–2020
6个月前
已完结
皖公网安备34019202002308
